CXCR1 correlates to poor outcomes of EGFR-TKI against advanced non-small cell lung cancer by activating chemokine and JAK/STAT pathway

Publication date: Available online 11 February 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Fang Yang, Shuai Zhang, Qingwei Meng, Fengrui Zhou, Bo Pan, Fang Liu, Yan Yu
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research